Literature DB >> 2947967

Contrasuppression in autoimmunity. Abnormal contrasuppression facilitates expression of nephritogenic effector T cells and interstitial nephritis in kdkd mice.

C J Kelly, E G Neilson.   

Abstract

We have used the murine model of spontaneous autoimmune interstitial nephritis in kdkd mice to examine the importance of abnormal immunoregulation in the expression of disease. T cells from naive congenic CBA/Ca mice suppress both histologic renal injury in the kdkd strain as well as the DTH reactivity to CBA/Ca renal tubular antigens mediated by lymphocytes from nephritic kdkd mice. These antigen-specific suppressor T cells are Lyt-2+, L3T4+, I-Jk+, genetically dominant and I-Jk restricted. Unfractionated spleen cells from young, prenephritic kdkd mice also demonstrate such suppressor function. Shortly preceding disease onset, however, net suppression is functionally bypassed by emergent contrasuppressor T cells. These regulatory cells are also Lyt-2+ and I-Jk+, and adhere both to the Vicia Villosa lectin and CBA/Ca TBM. By admixing these contrasuppressor cells with spleen cells from non-disease-prone CBA/Ca mice we were able to demonstrate the presence of DTH-reactive and nephritogenic effector cells in the latter population. Such nephritogenic effector cells could also be simply demonstrated after depletion of the suppressor cells with anti-I-Jk mAbs and complement. These findings support a role for contrasuppressor cells in the abrogation of tolerance to parenchymal self-antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947967      PMCID: PMC2188249          DOI: 10.1084/jem.165.1.107

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

Review 1.  Immunological circuits: cellular composition.

Authors:  H Cantor; R K Gershon
Journal:  Fed Proc       Date:  1979-06

2.  An inherited kidney disease of mice resembling human nephronophthisis.

Authors:  M F Lyon; E V Hulse
Journal:  J Med Genet       Date:  1971-03       Impact factor: 6.318

3.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

4.  Suppression of experimental autoimmune thyroiditis in the guinea pig by pretreatment with thyroglobulin in incomplete Freund's adjuvant.

Authors:  H Braley-Mullen; G C Sharp; M Kyriakos; N Hayes; C Dunn; P Jepsen; R D Sanders
Journal:  Cell Immunol       Date:  1978-09       Impact factor: 4.868

5.  Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.

Authors:  J E Swierkosz; R H Swanborg
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

6.  Immunoregulation of Heymann's nephritis. I. Induction of suppressor cells.

Authors:  A Litwin; J A Bash; L E Adams; R J Donovan; E V Hess
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. III. The role of adjuvants in the induction of disease.

Authors:  U H Rudofsky
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

8.  Renal tubulointerstitial lesions in CBA/J mice.

Authors:  U H Rudofsky
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

9.  Contrasuppression. A novel immunoregulatory activity.

Authors:  R K Gershon; D D Eardley; S Durum; D R Green; F W Shen; K Yamauchi; H Cantor; D B Murphy
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Immunoregulatory circuits that modulate responsiveness to suppressor cell signal. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the contrasuppressor circuit.

Authors:  K Yamauchi; D R Green; D D Eardley; D B Murphy; R K Gershon
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Selective T cell immunoregulatory function and contrasuppression in the mucosal immune system.

Authors:  L Braun-Elwert; S P James
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Preliminary characterization and distribution of vicia villosa binding cells in human tonsils.

Authors:  B M Almeida; J W Eveson; S J Challacombe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 3.  Contrasuppression in autoimmunity.

Authors:  C J Kelly; E G Neilson
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 4.  Phenotypic and functional characterization of human contrasuppressor cell interactions.

Authors:  T Lehner; R Brines
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 5.  Function and regulation of SRBC-induced contrasuppressor T cells which modulate suppression of MOPC-315 cell secretory differentiation in vivo and in vitro.

Authors:  J W Rohrer; J D Kemp
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 6.  Contrasuppression in the mucosal immune system.

Authors:  H Kiyono; D R Green; J R McGhee
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 7.  Role of contrasuppressor T cells in the antibody response to type III pneumococcal polysaccharide.

Authors:  H Braley-Mullen
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 8.  Induction of contrasuppression is restricted by genes mapping to the IgH locus.

Authors:  D R Green; B Chue; P M Flood
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 9.  The role of contrasuppression in tumor regression.

Authors:  P M Flood; A Friedman; J Freedman; B Horvat; P Reuter; W Ptak
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

10.  Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.